Tekst en media

Industry explained: (panel talk on stage)

Dr.         Kelly      Clark    Kelly Clark         President, Addiction Crisis Solutions
Dr.         Claire Ann         Banga  Claire Ann Banga          CEO & Chief Clinical Officer, eMoodie
Mr.         Yihua    Ning      Yihua Ning         CEO, SceneRay
Dr.         Alta       DeRoo  Alta DeRoo        Chief Medical Officer, Hazelden Betty Ford Foundation
Mr.         Patrik    Schmidle            Patrik Schmidle              CEO, CARI Health, Inc.

Industry Talk (non sponsored symposium)
This session explores how promising scientific discoveries can be translated into innovative treatments for addiction. It focuses on the collaboration between academia and industry to bridge the gap between basic research and clinical application. Key topics include the development and validation of new therapeutic targets, clinical research, regulatory pathways, financing, and bringing effective treatments to patients. The central message is clear: scientific innovation alone is not sufficient. Successful translation requires close collaboration between researchers, clinicians, industry and other stakeholders.

Industry-Academia Partnership for Innovations in Addiction Therapeutics
This session highlights the importance of industry-academia partnerships in accelerating the development of new approaches to addiction treatment. Emerging fields such as novel pharmacological targets, psychedelics, neuromodulation, digital technologies and artificial intelligence are creating new opportunities for innovation. The session explores how academic expertise and industrial development capabilities can complement each other to transform innovative ideas into clinically relevant, scalable and accessible therapies. Ultimately, these partnerships are essential for advancing addiction care and bringing effective new treatments to patients.